Primary study · included by 2 reviews

Treatment of post-orthodontic white spot lesions with casein phosphopeptide-stabilised amorphous calcium phosphate

Brochner 2011 · Bröchner Ann, Christensen Carsten, Kristensen Bjarne, et al. · Clinical Oral Investigations · 2010

doi:10.1007/s00784-010-0401-2journal-article

Trial PICO

Not extracted yet. Trial-level population, intervention, comparator, outcomes and design will appear here after the trial extraction run. Until then, the reviews below describe the study.

Results

Not extracted yet. Per-trial results (events, means, effect and weight as each review's forest plot reports them) will appear here after the trial extraction run.

Included by

Efficacy of fluorides and CPP-ACP vs fluorides monotherapy on early caries lesions: A systematic review and meta-analysis.

Non-Cochrane · intervention · 2018 · cited as Brochner 2011 · Table 1; Table 2; Fig 3 (QLF); Visual inspection scores; Reference 25

The review does not say which of its outcomes this study informs.

Evaluation of the efficacy of casein phosphopeptide-amorphous calcium phosphate on remineralization of white spot lesions in vitro and clinical research: a systematic review and meta-analysis.

Non-Cochrane · intervention · 2019 · cited as Bröchner 2014 · Table 1; Reference 26 (clinical, QLF; also informs P2-O1 vs baseline)

Outcome this study informs	Pooled effect	Evidence	Certainty
Quantitative light-induced fluorescence (QLF), fluorescence loss CPP-ACP paste (casein phosphopeptide-amorphous calcium phosphate; e.g., Tooth Mousse/MI Paste) vs Placebo paste without CPP-ACP (fluoride toothpaste control) · 4 weeks to 1 year	MD 0.08 [-0.91, 1.08]	2 studies · 129 participants	Ungraded

2 including reviews in total.